Ola Söderberg

Author PubWeight™ 67.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 2003 3.87
2 c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol 2005 3.79
3 Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002 3.00
4 In situ detection and genotyping of individual mRNA molecules. Nat Methods 2010 2.29
5 In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation method. Mol Cell Proteomics 2007 2.10
6 Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet 2002 1.97
7 A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood 2008 1.93
8 Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003 1.84
9 Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004 1.77
10 Flow cytometric in situ proximity ligation analyses of protein interactions and post-translational modification of the epidermal growth factor receptor family. Cytometry A 2009 1.73
11 Proximity ligation assays: a recent addition to the proteomics toolbox. Expert Rev Proteomics 2010 1.70
12 Parallel visualization of multiple protein complexes in individual cells in tumor tissue. Mol Cell Proteomics 2013 1.60
13 Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis. Proc Natl Acad Sci U S A 2008 1.59
14 WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies. PLoS Biol 2010 1.57
15 Novel and highly recurrent chromosomal alterations in Sézary syndrome. Cancer Res 2008 1.51
16 VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J 2010 1.37
17 Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation. J Cell Mol Med 2012 1.19
18 Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization. J Pathol 2012 1.16
19 Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN. Leuk Lymphoma 2007 1.11
20 High content screening for inhibitors of protein interactions and post-translational modifications in primary cells by proximity ligation. Mol Cell Proteomics 2009 1.10
21 Visualising individual sequence-specific protein-DNA interactions in situ. N Biotechnol 2011 1.10
22 Increasing the dynamic range of in situ PLA. Nat Methods 2011 1.08
23 Proximity ligation assays for sensitive and specific protein analyses. Anal Biochem 2005 1.07
24 MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas. Glycobiology 2009 1.05
25 Molecular tools for a molecular medicine: analyzing genes, transcripts and proteins using padlock and proximity probes. J Mol Recognit 2004 1.05
26 Functional interaction of DYX1C1 with estrogen receptors suggests involvement of hormonal pathways in dyslexia. Hum Mol Genet 2009 1.04
27 In situ proximity ligation assay for microscopy and flow cytometry. Curr Protoc Cytom 2011 1.01
28 Analysis of protein interactions in situ by proximity ligation assays. Curr Top Microbiol Immunol 2014 1.01
29 Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. Blood 2003 1.00
30 In situ detection of individual mRNA molecules and protein complexes or post-translational modifications using padlock probes combined with the in situ proximity ligation assay. Nat Protoc 2013 0.99
31 Protein tag-mediated conjugation of oligonucleotides to recombinant affinity binders for proximity ligation. N Biotechnol 2012 0.97
32 Analysis of genes, transcripts, and proteins via DNA ligation. Annu Rev Anal Chem (Palo Alto Calif) 2009 0.95
33 P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model. J Pathol 2013 0.93
34 V(H)3-21 gene usage in chronic lymphocytic leukemia--characterization of a new subgroup with distinct molecular features and poor survival. Leuk Lymphoma 2004 0.92
35 Prognostic but not predictive role of platelet-derived growth factor receptors in patients with recurrent glioblastoma. Int J Cancer 2011 0.91
36 Functional overlap between chondroitin and heparan sulfate proteoglycans during VEGF-induced sprouting angiogenesis. Arterioscler Thromb Vasc Biol 2012 0.91
37 Padlock and proximity probes for in situ and array-based analyses: tools for the post-genomic era. Comp Funct Genomics 2003 0.88
38 The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC. Eur J Hum Genet 2012 0.87
39 Intercellular variation in signaling through the TGF-β pathway and its relation to cell density and cell cycle phase. Mol Cell Proteomics 2012 0.85
40 Western blotting via proximity ligation for high performance protein analysis. Mol Cell Proteomics 2011 0.85
41 Platelet-derived growth factor receptor expression and activation in choroid plexus tumors. Am J Pathol 2009 0.84
42 U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner. Eur J Haematol 2008 0.82
43 Simultaneous visualization of both signaling cascade activity and end-point gene expression in single cells. PLoS One 2011 0.82
44 Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome. Haematologica 2005 0.80
45 Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia. Leuk Res 2004 0.80
46 ADP-ribosylation factor 6 mediates E-cadherin recovery by chemical chaperones. PLoS One 2011 0.79
47 Molecular tools for companion diagnostics. N Biotechnol 2012 0.79
48 Prospects for in situ analyses of individual and complexes of DNA, RNA, and protein molecules with padlock and proximity probes. Methods Cell Biol 2004 0.79
49 Ligation-based molecular tools for lab-on-a-chip devices. N Biotechnol 2008 0.78
50 Automated classification of multicolored rolling circle products in dual-channel wide-field fluorescence microscopy. Cytometry A 2011 0.78
51 Thermoplastic microfluidic platform for single-molecule detection, cell culture, and actuation. Anal Chem 2005 0.76
52 Association of the protein-tyrosine phosphatase DEP-1 with its substrate FLT3 visualized by in situ proximity ligation assay. PLoS One 2013 0.76
53 Differentiation-associated redox-regulation in human B cell lines from stem cell/pro-B to plasma cell. Immunol Lett 2004 0.76
54 Methods for analysis of the cancer microenvironment and their potential for disease prediction, monitoring and personalized treatments. EPMA J 2012 0.76
55 Corrigendum: Insufficient antibody validation challenges oestrogen receptor beta research. Nat Commun 2017 0.75
56 Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma. Leuk Lymphoma 2007 0.75